APPLICATIONS PUBLISHED 25 MAY

Ophthalmic ointment compsn comprising a drug, an ointment base and a solubilising/ dispersing agent
Novartis 1531793*

Inhalable epinephrine
Advanced Inhalation Research 1531794*

Formulations limiting spread of pulmonary infections
President and Fellows of Harvard College 1531795*

Microparticles with adsorbed polypeptide-containing molecules
Chiron Corp 1531796*

Biodegradable block copolymeric compsns for drug delivery
Macromed 1531797*

Pulmonary delivery for levodopa
Advanced Inhalation Research 1531798*

Nanoparticulate formulations comprising HMG CoA reductase inhibitor derivatives ("statins.), novel combinations thereof as well as manufacturing of these pharmaceutical compsns
Elan Pharma 1531799*

Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
Ethypharm 1531800*

Combination of an allosteric inhibitor or matrix metalloproteinase-13 with selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
Warner-Lambert 1531801*

Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylphedrine
Boehringer Ingelheim International 1531802*

Method of inhibiting prostate cancer cell proliferation
Scott, Kieran Francis 1531803*

Method of inhibiting angiogenesis
The Queen Elizabeth Hospital Research Foundation 1531804*

Compsn comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilising agent
Merck Sharp & Dohme; Schering 1531805*

Use of thio-oxindole derivatives in treatment of hormone-related conditions
Wyeth 1531806*

Bazedoxifene treatment regimens
Wyeth 1531807*

Peroxynitrine rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions
Schering 1531808*

AT1-receptor antagonists for preventing secondary strokes
Solvay Pharmaceuticals 1531809*

Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Bristol-Myers Squibb 1531810*

Derivatives of 3-hydroxy-4-(cyclyl=alkylaminoalkyl)-5-phenyl-1H-pyrazole as antagonists of the gonadotrophin-releasing hormone (GNRH) for use in the treatment of sex hormone related conditions, such as prostatic or uterine cancer
AstraZeneca 1531811*

Fused heteroaryl derivatives for use as P38 kinase inhibitors in the treatment of I A. rheumatoid arthritis
SmithKline Beecham 1531812*

Use of compounds for increasing spermatozoa motility
Applied Research Systems 1531813*

Sustained-release tablet compsn of pramipexole
Pharmacia 1531814*

Glucokinase activators
Novo Nordisk 1531815*

Spirocyclic piperidines as MCH1 antagonists and uses thereof
H Lundbeck 1531816*

Glycinamide derivatives as RAF-kinase inhibitors
Marck Patent 1531817*

Topical treatment of skin diseases
Elbion 1531818*

Use of I kappa B kinase inhibitors for the treatment of pain
Aventis Pharma Deutschland 1531819*

Anabaseine derivatives useful in the treatment of neurodegenerative diseases
Memory Pharmaceuticals 1531820*

Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matric metalloproteinase inhibitors
AstraZeneca 1531821*

1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
Chemocentryx 1531822*

Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
The Ohio State University 1531823*

Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders
Wyeth 1531824*

Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
University of Southampton 1531825*

Prophylaxis and treatment of infectious diseases
Gulbins, Erich 1531826*

Copper lowering treatment of inflammatory and fibrotic diseases
The Regents of the University of Michigan 1531827*

Methods of treating bacterial infections and diseases associated therewith
Activbiotics 1531828*

Infertility treatment with exemestane
Pharmacia & Upjohn; Wajszcuk, Charles; Dekoning Gans, Hendrik 1531829*

Methods of reducing C-rective protein levels with non-antibacterial tetracycline formulations
The Research Foundation of State University of New York 1531830*

Fosinopril formulation
Delta 1531831*

Therapeutic compsns for use in prophylaxis or treatment of diarrhoeas
Glykos Finland 1531832*

Antisense compounds, methods and compsns for treating MMP-12 related inflammatory disorders
Index Pharmaceuticals 1531833*

Antisense compounds, methods and compsns for treating NGAL-related disorders
Index Pharmaceuticals 1531834*

Micelle assemblies
Rutgers, the State University of New York 1531835*

Polypeptide cleavage process
Restoragen 1531836*

Compsns and methods for the prophylaxis and treatment of aphtheous ulcers and herpes simplex lesions
Chiou Consulting 1531837*

Stem cells for treating pancreatic damage
Asahi KK 1531838*

Avian appeasing pheromones to decrease stress, anxiety and aggresiveness
Fideline 1531839*

Probiotics for gut neuromuscular functions
Nestec 1531841*

Regulation of cell growth by MUC-1
Dana Farber Cancer Institute 1531842*

Method for treating cervical cancer
ZymoGenetics 1531843*

Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
New River Pharmaceuticals 1531844*

Inhibitors for use in haemostasis
ZymoGenetics 1531845*

Conjugates of ligand, linker and cytotoxic agent and related compsns and methods of use
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1531846*

Pharmaceutical formulation
Abbott Laboratories 1531847*

O-derivatised nocathiacin derivatives
Bristol-Myers Squibb 1531854*

Treatment of bone disorders with skeletal anabolic drugs
Osteotrophin 1531855*

Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
Amgen 1531856*

Metalloproteinase inhibitors
GroPep 1531857*

Immunogenic compsns comprising a fusion protein and a saponin adjuvant
Akzo Nobel 1531858*

Compsns and methods for transepithelial molecular transport
Thomas Jefferson University 1531859*

Peptides for chlamydophila pneumoniae vaccine and diagnosis
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1531859*

Structural carotenoid analogues for the inhibition and amelioration of disease
Hawaii Biotech 1532108*

Pyrrolidine derivatives as oxytocin antagonists
Applied Research Systems 1532109*

Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipene)
Erregierre 1532110*

2,5-disubstituted 3-mercaptopentanoic acid
AstraZeneca 1532111*

Process for the preparation or modification of N-91-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulphonamide
Pliva Hrvatska 1532112*

Substituted dihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compsns and uses thereof
Boehringer Ingelheim Pharmaceuticals 1532113*

Process for preparing quinolone antibiotic intermediates
Procter & Gamble 1532114*

Protease inhibitors
SmithKline Beecham 1532115*

1H-pyrazol derivatives, method for producing the same and the use thereof as nitrification inhibitors
SKW Stickstoffwerke Piesteritz 1532116*

Multi-substituted imidazoles and method of use thereof
Michigan State University 1532117*

Imidazole compounds for the treatment of hepatitis C virus infections
Axxima Pharmaceuticals 1532118*

Aryl substituted benzimidazoles and their use as sodium channel blockers
Euro-Celtique 1532119*

Phenylpyridazine derivatives as ligands for GABA receptors
Merck Sharpe & Dohme 1532120*

New use of pyrimidine- or triazine-2-carbonitriles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitrile derivatives
AstraZeneca 1532121*

11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidaemia
Merck 1532122*

Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
Pharmacia & Upjohn 1532123*

Novel compounds
AstraZeneca 1532124*

Sorbicillactone-A derivatives for the treatment of tumour and viral diseases
Johannes Gutenburg-Universitaet Mainz 1532129*

Process for the production of an immunosuppressant
Biocon 1532130*

Motilide compounds
Kosan Biosciences 1532131*

Novel benzodioxoles
F Hoffmann-La Roche 1532132*

NF-B inhibitors
SmithKline Beecham 1532133*

Novel thiphene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compsns and novel use
Aventis Pharma 1532134*

NF-KB inhibitors
SmithKline Beecham 1532135*

Pyridazine derivatives as ligands for GABA receptors
Merck Sharp & Dohme 1532136*

Antimicrobial aza-bicyclic derivates, their compsns and uses
Procter & Gamble 1532137*

Inhibitors of tyrosine kinases
Novartis 1532138*

Total synthesis of myriaporones
Pharma Mar 1532139*

Thienylhydrazon with digitalis-like properties (positive inotropic effects)
University of Maryland 1532140*

2-pyrrolidin-2-yl-, 1,3,4]-oxadiazolede derivatives and the use of the same as antidepressants
Gruenenthal 1532141*

Polypeptide cleavage process
Restoragen 1532142*

Methods for producing hydroxyaslkyl tropane esters
Entropin 1532143*

Novel quinuclidine derivatives and their use
Neurosearch 1532144*

Pyrazole compsns useful as inhibitors of GSK-3
Vartex Pharmaceuticals 1532145*

A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
Neurosearch 1532146*

Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
Schering 1532147*

Novel pruine- or pyrrolol(2,3-D)pyrimidine-2-carbonitriles for treating diseases associated with cysteine protease activity
AstraZeneca 1532148*

8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments
Boehringer Ingelheim Pharma 1532149*

Novel purine derivatives, production and use thereof as medicaments
Boehringer Ingelheim Pharma 1532150*

Crystalline solid famciclovir forms I, II, III and preparation thereof
Teva Pharmaceutical Industries 1532151*

Novel polymorph of N-methyl-N-(3,3-2-thienylcarbonyl)pyrazol-1,5-alpha)-pyrimidin-7-yl phenyl)acetamide and compsns and methods related thereto
Neurocrine Biosciences 1532152*

Azepinoindole and pyridoindole derivatives as pharmaceutical agents
X-Ceptor Therapeutics 1532153*

Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
AstraZeneca 1532154*

C6- and C9-substituted chromeno[4,3-C]isoxazoline derivatives and their use as antidepressants
Janssen Pharmaceutica 1532155*

Dihydrocarbylamino metal compounds
Albemarle 1532156*

Novel phosphonic acid based prodrugs of PMEA and its analogues
Metabasis Therapeutics 1532157*

Natural metallic dendrimer complexes
Isis Innovation 1532158*

Scaffolded malemide clusters for multivalent peptide assembly
University of Maryland Biotechnology Institute 1532159*

Antisense modulation of insulin-like growth factor 2 expression
Isis Pharmaceuticals 1532160*

Vectors for expression of HML-2 polypeptides
Chiron 153216*

Humanised anti-tag-72 CC49 for diagnosis and therapy of human tumours
The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services 1532162*

Androgen receptor coregulators
University of Rochester 1532163*

Template-fixed peptidomimetics with antibacterial activity
Polyphor 1532164*